8AHF

PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.27 Å
  • R-Value Free: 0.238 
  • R-Value Work: 0.177 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history


Literature

PAC-FragmentDEL - photoactivated covalent capture of DNA-encoded fragments for hit discovery.

Ma, H.Murray, J.B.Luo, H.Cheng, X.Chen, Q.Song, C.Duan, C.Tan, P.Zhang, L.Liu, J.Morgan, B.A.Li, J.Wan, J.Baker, L.M.Finnie, W.Guetzoyan, L.Harris, R.Hendrickson, N.Matassova, N.Simmonite, H.Smith, J.Hubbard, R.E.Liu, G.

(2022) RSC Med Chem 13: 1341-1349

  • DOI: https://doi.org/10.1039/d2md00197g
  • Primary Citation of Related Structures:  
    8AHE, 8AHF, 8AHG, 8AHH, 8AHI

  • PubMed Abstract: 

    We describe a novel approach for screening fragments against a protein that combines the sensitivity of DNA-encoded library technology with the ability of fragments to explore what will bind. Each of the members of the library consists of a fragment which is linked to a photoactivatable diazirine moiety. Split and pool synthesis combines each fragment with a set of linkers with the version of the library reported here containing some 70k different compounds, each with an individual DNA code. Incubation of the library with a protein sample is followed by photoactivation, washing and subsequent PCR and sequencing which allows the individual fragment hits to be identified. We illustrate how the approach allows successful hit fragment identification using only microgram quantities of material for two targets. PAK4 is a kinase for which conventional fragment screening has generated many advance leads. The as yet undrugged target, 2-epimerase, presents a more challenging active site for identification of hit compounds. In both cases, PAC-FragmentDEL identified fragments validated as hits by ligand-observed NMR measurements and crystal structure determination of off-DNA sample binding to the proteins.


  • Organizational Affiliation

    HitGen Inc. Building 6, No. 8 Huigu First East Road, Tianfu International Bio-Town, Shuangliu District Chengdu 610000 Sichuan P. R. China huiyong.ma@hitgen.com hd.luo@hitgen.com xm.cheng@hitgen.com qx.chen@hitgen.com chao.song@hitgen.com cong.duan@hitgen.com ping.tan@hitgen.com lf.zhang@hitgen.com jian.liu@hitgen.com barry.morgan@hitgen.com jin.li@hitgen.com jq.wan@hitgen.com gs.liu@hitgen.com.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
UDP-N-acetylglucosamine 2-epimerase
A, B
375Bacillus anthracisMutation(s): 0 
Gene Names: GBAA_5509
EC: 5.1.3.14
UniProt
Find proteins for A0A348ACF3 (Bacillus anthracis)
Explore A0A348ACF3 
Go to UniProtKB:  A0A348ACF3
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A348ACF3
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
M3U (Subject of Investigation/LOI)
Query on M3U

Download Ideal Coordinates CCD File 
C [auth A],
J [auth B]
(2~{R},4~{S})-4-[bis(fluoranyl)methoxy]-~{N}-methyl-1-(2~{H}-pyrazolo[4,3-b]pyridin-6-ylcarbonyl)pyrrolidine-2-carboxamide
C14 H15 F2 N5 O3
IIQVNHRKCWVSPV-GZMMTYOYSA-N
SO4
Query on SO4

Download Ideal Coordinates CCD File 
D [auth A]
E [auth A]
F [auth A]
G [auth A]
H [auth A]
D [auth A],
E [auth A],
F [auth A],
G [auth A],
H [auth A],
I [auth A],
K [auth B],
L [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.27 Å
  • R-Value Free: 0.238 
  • R-Value Work: 0.177 
  • Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 109.315α = 90
b = 109.315β = 90
c = 135.866γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2022-09-14
    Type: Initial release
  • Version 1.1: 2022-12-07
    Changes: Database references
  • Version 1.2: 2024-01-31
    Changes: Data collection, Refinement description